Here it was demonstrated that the combination of CD40 stimulation, WBI and ACT enhanced the proliferation of infused T cells, promoted high levels of tumor inflammation and was associated with tumor regression and prolonged survival of treated mice. This evidence concerns the gene CD40 and neoplasm.